Announcements Trials
Browse Landscape

Phase

Phase 1 61Phase 2 40Phase 1/2 14Phase 3 12Phase NA 2Phase 4 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Breast Neoplasms 5Small Cell Lung Carcinoma 3Thoracic Neoplasms 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Neoplasms 2Lung Diseases 2Carcinoma, Large Cell 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-small Cell Lung Cancer Metastatic 1Non-Small Cell Lung Cancer Metastatic 1Neoplasms, Second Primary 1Neoplasms by Site 1Nasopharyngeal Neoplasms 1NSCLC 1Medulloblastoma 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Bronchogenic 1Carcinoma 1Cancer Therapy-related Cardiovascular Toxicity 1Bronchial Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Carboplatin × Clear all
NCT07279935 2026-03-19

REVIVE

AstraZeneca

Phase 4 Not yet recruiting
100 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT02103244 2014-04-03

Validation of an Adjusted Dosing Algorithm of Carboplatin

Rijnstate Hospital

Phase 4 Unknown
24 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡